// App-Quantinova.ai

: Use of Basiliximab as initial immunosuppression for liver transplantation is renal protective

Researchers

Presenter

  • D.A. Longbotham

Principal Investigators

  • R. Pande

  • D. Vijayanand

  • R. Prasad

  • M. Attia

Medical Centers

  • Department of HPB and Transplantation, St James' University Hospital, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Basiliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved